Financial & SEC Reports
Here you will find a summary of Celldex Therapeutics, Inc.'s latest financial information.
Latest 10-Q
Latest Annual Report and 10-K
Latest Proxy Statement
Share Related Items
| Market Capitalization (Mil) $ | 2,523.50 |
| Shares Outstanding (Mil) | 46.48 |
| Shares Outstanding, Average (FY) (Mil) | 29.64 |
| Float (Mil) | 43.62 |
Data provided by Kaleidoscope.
FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.
